Chiesi USA, Inc.

Chiesi USA, Inc. is a leading global pharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. Established with a strong commitment to improving patient outcomes, Chiesi focuses on therapeutic areas such as respiratory diseases, neonatology, and rare diseases.

The company operates with a vision to enhance the quality of life for patients worldwide through cutting-edge science and technology. With a robust pipeline of products, Chiesi aims to address unmet medical needs and provide effective solutions for healthcare professionals.

Chiesi USA, Inc. prides itself on its ethical approach to business, ensuring that all operations are conducted with integrity and transparency. The company fosters a culture of collaboration and innovation, encouraging its employees to contribute to the development of new therapies.

In addition to its commitment to healthcare, Chiesi is also dedicated to sustainability and social responsibility. The company actively engages in initiatives that promote environmental stewardship and community well-being.

Core Activities:

• Research and Development of Pharmaceuticals
• Commercialization of Innovative Medicines
• Focus on Respiratory Diseases, Neonatology, and Rare Diseases

With a strong presence in the pharmaceutical industry, Chiesi USA, Inc. continues to expand its reach and impact, striving to be a trusted partner in healthcare.